Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients

Transplantation

Volumn 90, Issue 9, 2010, Pages 1000-1005

  Zarkhin, Valeriya ^a   Talisetti, Anita ^a   Li, Li ^a   Wozniak, Laura J ^b   McDiarmid, Sue V ^b   Cox, Kenneth ^a   Esquivel, Carlos ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HLA G; Pediatric liver transplantation; Tolerance

Indexed keywords

CYCLOSPORIN; HLA G ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; ALAGILLE SYNDROME; ANTIGEN EXPRESSION; ARTICLE; BILE DUCT ATRESIA; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DRUG WITHDRAWAL; EFFECTOR CELL; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INTRAHEPATIC CHOLESTASIS; LIVER FUNCTION; LIVER GRAFT; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; NEWBORN HEPATITIS; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGE FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; INFANT; LIVER TRANSPLANTATION; MALE; PREDICTIVE VALUE OF TESTS; SEX CHARACTERISTICS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650261798     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181f546af     Document Type: Article

References (35)

1. Kovats S, Main EK, Librach C, et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220.
2. Le Rond S, Azema C, Krawice-Radanne I, et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immuno-suppressive/ regulatory T cells. J Immunol 2006; 176: 3266.
3. Selmani Z, Naji A, Gaiffe E, et al. HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells. Transplantation 2009; 87(9 suppl): S62.
4. Pistoia V, Morandi F, Wang X, et al. Soluble HLA-G: Are they clinically relevant? Semin Cancer Biol 2007; 17: 469.
5. Paul P, Cabestre FA, Ibrahim EC, et al. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol2000; 61: 1138.
6. Le Gal FA, Riteau B, Sedlik C, et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999; 11: 1351.
7. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4( + ) T-lymphocytes. J Reprod Immunol 2000; 48: 17.
8. Bahri R, Hirsch F, Josse A, et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006; 176: 1331.
9. Rouas-Freiss N, Marchal RE, Kirszenbaum M, et al. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 1997; 94: 5249.
10. Rouas-Freiss N, Goncalves RM, Menier C, et al. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520.
11. Rebmann V, LeMaoult J, Rouas-Freiss N, et al. Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 2007; 69(suppl 1): 143.
12. Ristich V, Liang S, Zhang W, et al. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005; 35: 1133.
13. + cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33: 125.
14. Rouas-Freiss N, Moreau P, Menier C, et al. HLA-G in cancer: A way to turn off the immune system. Semin Cancer Biol 2003; 13: 325.
15. Aractingi S, Briand N, Le Danff C, et al. HLA-G and NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells? Am J Pathol 2001; 159: 71.
16. Wiendl H, Feger U, Mittelbronn M, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: Implications for CNS immunity. Brain 2005; 128(pt 11): 2689.
17. Lozano JM, Gonzalez R, Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. Aids 2002; 16: 347.
18. Bahri R, Naji A, Menier C, et al. Dendritic cells secrete the immuno-suppressive HLA-G molecule upon CTLA4-Ig treatment: Implication in human renal transplant acceptance. J Immunol 2009; 183: 7054.
19. Sheshgiri R, Rouas-Freiss N, Rao V, et al. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2008; 27: 522.
20. Racca AL, Veaute CM, Bailat AS,etal. Expressionof HLA-G and MICA mRNA in renal allograft. Transpl Immunol 2009; 21: 10.
21. Lila N, Amrein C, Guillemain R, et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949.
22. Brugiere O, Thabut G, Pretolani M, et al. Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 2009; 9: 1427.
23. Basturk B, Karakayali F, Emiroglu R, et al. Human leukocyte anti-gen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 2006; 38: 571.
24. RebmannV,BartschD, WunschA,etal. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol 2009; 70: 995.
25. Crispim JC, Duarte RA, Soares CP, et al. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection. Transpl Immunol 2008; 18: 361.
26. Creput C, Durrbach A, Menier C, et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003; 39: 587.
27. Creput C, Le Friec G, Bahri R, et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: Possible implications for monitoring patients. Hum Immunol 2003; 64: 1033.
28. Creput C, Durrbach A, Charpentier B, et al. [HLA-G: Immunoregulatory molecule involved in allograft acceptance]. Nephrologie 2003; 24: 451.
29. Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638.
30. Ng VL, Fecteau A, Shepherd R, et al. Outcomes of 5-year survivors of pediatric liver transplantation: Report on 461 children from a north american multicenter registry. Pediatrics 2008; 122: e1128.
31. Carosella ED, Moreau P, Le Maoult J, et al. HLA-G molecules: From maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003; 81: 199.
32. Rouas-Freiss N, LeMaoult J, Moreau P, et al. HLA-G in transplantation: A relevant molecule for inhibition of graft rejection? Am J Transplant 2003; 3: 11.
33. Rudstein-Svetlicky N, Loewenthal R, Horejsi V, et al. HLA-G levels in serum and plasma. Tissue Antigens 2007; 69(suppl 1): 140.
34. Sheshgiri R, Gustafsson F, Sheedy J, et al. Everolimus but not my-cophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients. J Heart Lung Transplant 2009; 28: 1193.
35. Levitsky J, Miller J, Wang E, et al. Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents. Hum Immunol 2009; 70: 146.